NEWSDemocratizing Access to Life-Changing Medications: MyStart Health’s Mission to Redefine Personalized Care in Weight Loss
April 18 2025, Published 1:02 a.m. ET
Summary: MyStart Health is democratizing access to GLP-1 medications and personalized weight loss solutions through an innovative, patient-centered telemedicine platform.
Matthew Stern
Obesity and being overweight remain two of the most persistent public health challenges today. Weight loss has, therefore, become a matter of life and longevity for millions of people globally. MyStart Health, a telemedicine company founded by entrepreneur and healthcare advocate Matthew Stern, aims to improve how people access cutting-edge medical treatments. It offers personalized weight loss solutions anchored by GLP-1 medications.
The streamlined and efficient platform for weight loss that MyStart Health provides is essential, with more than one in three adults in the United States living with obesity. Obesity is a leading risk factor for numerous chronic diseases, including type 2 diabetes, hypertension, and several forms of cancer. In addition to the human toll, the economic burden is also worth noting. Obesity-related healthcare costs in the US total over $260 billion.
Even modest weight loss can significantly reduce the risk of chronic conditions. Research shows that GLP-1 receptor agonists (medications originally developed for type 2 diabetes) can produce a 15–20% reduction in body weight when used alongside lifestyle modifications. This finding implies that losing only 5-10% of body weight can improve blood sugar levels, lower blood pressure, and reduce the risk of heart disease.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide (branded as Wegovy and Ozempic) have earned attention for obesity treatment. These medications work by regulating appetite, slowing gastric emptying, and improving insulin sensitivity. The STEP clinical trials, among the most comprehensive studies on semaglutide, found that participants who adhered to a structured GLP-1-based program sustained weight loss over 104 weeks.
Dr. Ritu Chopra
Want OK! each day? Sign up here!
The problem is that access is still a barrier. Insurance limitations, high out-of-pocket costs, and a fragmented healthcare system have hindered many Americans from benefiting from these innovations. MyStart Health aims to make effective, medically supervised weight loss accessible and affordable. Supported by the expert clinical guidance of Dr. Ritu Chopra and a patient-first philosophy, MyStart provides personalized telehealth-based programs that center on GLP-1 medications.
The company’s mission stems from the experience of its founder. “After losing my father to preventable complications of cardiovascular disease, I realized how inaccessible and fragmented healthcare can be,” Stern shares. “MyStart was created to offer people a simpler, more effective way to address weight-related health challenges. Had my father had access to something like this, I believe he would still be with us today.”
MyStart Health stands out for its approach. It believes weight loss isn’t one-size-fits-all. Hence, it offers injectable and oral variations of GLP-1 medications, tailoring dosage and administration to meet each patient’s needs. Several companies now offer access to GLP-1 medications. MyStart Health, registered in all 50 states, differentiates itself with a network of over 600 physicians and a patient advocacy team on standby.
“We’re constantly evaluating new treatments, from next-generation peptides to advanced diagnostic tools. But we’re most proud of the customized, convenient, and compassionate way we deliver care,” Stern says.
The patient journey at MyStart Health is simple. They only need to complete a brief health assessment to connect with licensed providers for same-day consultations. Once approved, medications are shipped directly to their door (usually within 48 hours). This is how the company removes the friction from traditional healthcare.
Moreover, MyStart Health offers unlimited telehealth visits and 24/7 concierge support. “We know patients have questions, and we’re here for them every step of the way,” Stern says. “Our entire business is built around ensuring patients feel supported, informed, and empowered throughout their journey.”
Confident in its impact and dedicated to accountability and patient trust, MyStart Health offers a 90-day guarantee. Patients who comply with the program for three months and fail to lose weight are eligible for a full refund. They can also use HSA/FSA funds and request itemized receipts for reimbursement, avoiding the red tape of insurance that usually delays care. “Many insurers pull back from covering GLP-1s because of cost. That’s why we employ transparent, cash-based pricing,” Stern states.
Last but not least, MyStart Health is LegitScript certified. This certification ensures the company fully complies with healthcare regulations and provides patients with an added layer of trust and safety.
GLP-1-supported weight management is MyStart Health’s current focus. However, it also has plans to expand its telehealth offerings to include blood diagnostics, hormone optimization, sexual wellness, and anti-aging programs. “We see MyStart evolving into a holistic wellness platform,” Stern shares. This vision reinforces the company’s broader mission of providing individuals with the tools they need to live longer, healthier lives.
